NCT05477355

Brief Summary

This study is a type 2 hybrid implementation design, which aims to evaluate the utility and effectiveness of an intervention while simultaneously assessing implementation outcomes, such as adoption, fidelity, and maintenance. The aim is to compare participant level outcomes when the intervention is delivered by facilitators that are trained and supervised by psychologists versus by lay-supervisors. Group PM+ will be delivered to participants in two phases: first, with high levels of technical support through intensive training and supervision by mental health professionals and a second phase with routine service delivery and supervision. Non-specialist community members who are trained and supervised by psychologists to deliver PM+ as part of Phase 1 will be trained to become supervisors and train and support a cohort of new non-specialist facilitators for Group PM+ delivery in Phase 2. This model employs a train-the-trainers model to replicate routine service delivery especially in settings where mental health specialists may not be available to provide robust technical support and supervision to lay PM+ facilitators. The aim is to compare effectiveness and implementation outcomes of Group PM+ when delivered within routine care, to identify best practices for implementation, and ultimately, to shorten the time lag between intervention research and routine uptake.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 19, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 28, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

July 28, 2022

Status Verified

July 1, 2022

Enrollment Period

11 months

First QC Date

July 19, 2022

Last Update Submit

July 25, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Patient Health Questionnaire 9 (PHQ-9)

    a well-known 10-item instrument that measures symptoms of depression and general distress. It has been used in prior PM+ studies as the primary participant level outcome. Scoring between 5-9 points indicates mild depression, 10-14 points indicates moderate depression, 15-19 points indicates moderately severe depression, and 20 or more points indicates severe depression.

    4 months after baseline

Secondary Outcomes (4)

  • Post-traumatic stress disorder Checklist (PCL-5)

    4 months after baseline

  • Psychological Outcome Profiles (PSCYHLOPS)

    4 months after baseline

  • Reducing Tension Checklist (RTC)

    4 months after baseline

  • Alcohol use disorders identification test (AUDIT)

    4 months after baseline

Study Arms (2)

Intervention Arm

EXPERIMENTAL

Participants will be provided the 5 session intervention.

Behavioral: Group Problem Management Plus (PM+)

Wait list control arm

ACTIVE COMPARATOR

Participants will not be provided Group PM+ in Phase 1 but will be provided the intervention after all participants in the initial intervention arm receive Group PM+.

Behavioral: Group Problem Management Plus (PM+)

Interventions

Group PM+ is a low-intensity, trans-diagnostic, brief psychological intervention developed by the WHO. Group PM+ consists of five sessions delivered in five consecutive weeks and includes strategies that are aimed towards decreasing symptoms of depression, anxiety, general distress, and other related conditions. Group PM+ is designed to be delivered by non-specialists, persons without a formal education and licensure in psychology or mental health.

Intervention ArmWait list control arm

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Gender Eligibility DetailsParticipants that self-identify as women are eligible for the study
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • must identify as a woman
  • over 18 years of age
  • must state that they are planning to live in Barranquilla for at least three months after the date of screening
  • moderate functional impairment as indicated by scoring greater than 16 on the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) for health and disability
  • moderate psychological distress as indicated by scoring greater than 2 on the General Health Questionnaire 12 (GHQ-12)

You may not qualify if:

  • imminent risk of suicide and state that they have plans for attempting suicide
  • show severe cognitive impairment (e.g. severe intellectual disability or dementia) or a severe disability as identified by the Ten Questions (TQ-10)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

HIAS

Barranquilla, Colombia

RECRUITING

Study Officials

  • Adam Brown, PhD

    The New School

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Manaswi Sangraula, PhD

CONTACT

Adam Brown, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Participants in wait list control (WLC) are explained that they will be receiving the intervention at a later time.
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: The intervention is Group Problem Management Plus (PM+).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 19, 2022

First Posted

July 28, 2022

Study Start

February 1, 2022

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

July 28, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

All participant data will anonymized when input into databases. Individual participant data will only be available to those on the research team.

Locations